Jamie S. Myers, PhD, RN, AOCN

Adjunct Assistant Professor

Email: jmyers@kumc.edu
Phone: (913) 449-5996

Jamie Myers, PhD, RN, AOCN, adjunct assistant professor, joined the University of Kansas School of Nursing during the Spring 2011 semester. Dr. Myers is licensed to practice in Kansas and Missouri.

Dr. Myers is an oncology clinical nurse specialist and scientific director. In that position she coordinates activities related to the conduct of oncology clinical trials and the exchange of scientific information between her organization and three national research networks. She also is responsible for educating research network staff about the mechanisms of action and emerging trial data related to the clinical trials and the drug development pipeline. She meets regularly with research network executives and staff to identify and resolve issues pertinent to the clinical trial partnership. Dr. Myers' areas of research interest are survivorship issues and side effect management for individuals with cancer. She is conducting ongoing research in the area of chemotherapy-related cognitive impairment.

 

Professional Credentials

• Certification by the Oncology Nursing Certification Corporation as an Advanced Oncology Certified Nurse (AOCN)

Awards

• 1st Annual AOCN of the Year, Greater Kansas City Chapter, Oncology Nursing Society, 2002
• Literary Guild Award, Greater Kansas City Chapter, Oncology Nursing Society, 1998
• Kansas Division Quality of Life Award, American Cancer Society, 1992-1993

Professional Organizations

• Golden Key International Honor Society
• The Honor Society of Phi Kappa Phi
• Oncology Nursing Society   

Recent Articles

• Myers, J.S., Sousa, V.D, & Donovan, H.S., Predictors of self-reported memory problems in patients with ovarian cancer who have received chemotherapy, Oncology Nursing Forum, 37(5), September 2010, 596-603.
• Myers J.S., Grigsby, J., Teel, C.S., & Kramer, A. Nurses’ assessment of rehabilitation potential and prediction of functional status at discharge from inpatient rehabilitation, International Journal of Rehabilitation Research, 32(3), September 2009, 264-266.
• Myers, J.S., Chemotherapy-related cognitive impairment: Neuroimaging, neuropsychologic testing and the neuropsychologist, Clinical Journal of Oncology Nursing, 13(4), August 2009, 413-421
• Myers, J.S., A comparison of the theory of unpleasant symptoms with the conceptual model of chemotherapy-related changes in cognitive function, Oncology Nursing Forum, 36(1), January 2009, E1-E10.

Recent Texts

•  Myers, J.S. Oncology Nurse’s Perspective, in Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment, Robert B Raffa and Ronald J. Tallarida (eds). Advances in Experiementa Medicine and Biology, Vol 678, New York: Landes Bioscience, 2010.
• Myers, J.S. Neuropsychologic Testing for Chemotherapy-Related Cognitive Impairment, in Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment, Robert B Raffa and Ronald J. Tallarida (eds). Advances in Experiementa Medicine and Biology, Vol 678, New York: Landes Bioscience, 2010.
• Myers, J.S. The Possible Role of Cytokines in Chemotherapy-Induced Cognitive Deficits, in Chemo Fog: Cancer Chemotherapy-Related Cognitive Impairment, Robert B Raffa and Ronald J. Tallarida (eds). Advances in Experiementa Medicine and Biology, Vol 678, New York: Landes Bioscience, 2010.
• Myers, J.S. & Klemp, J.R. Chemotherapy-Related Cognitive Changes, in Personalized Approach to Cancer Survivorship, Joanne Lester & Pat Schmitt (eds). In press.

Biosketch